CSIMarket
 
Ra Medical Systems Inc   (RMED)
Other Ticker:  
 
 
Price: $0.5940 $0.05 10.000%
Day's High: $0.594 Week Perf: -5.89 %
Day's Low: $ 0.52 30 Day Perf: -16.34 %
Volume (M): 78 52 Wk High: $ 7.25
Volume (M$): $ 46 52 Wk Avg: $2.10
Open: $0.55 52 Wk Low: $0.52



 Market Capitalization (Millions $) 1,620
 Shares Outstanding (Millions) 2,726
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -88
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 0

Ra Medical Systems Inc


   Company Address: 1670 Highway 160 West, Suite 205 Fort Mill 29708 SC
   Company Phone Number: 691-2000   Stock Exchange / Ticker: NYSE RMED
   RMED is expected to report next financial results on March 27, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Vystar Corporation

Vystar Corporation's Financial Report Reveals Shocking Decline: Stakeholders Left Disappointed



Vystar Corporation, a renowned company in the industry, recently released its financial report for the second quarter of 2023. Unfortunately, the figures have left stakeholders and investors disappointed. The report reveals a substantial decline in revenue, an increase in shortfall per share, and a net deficit compared to the previous year's figures. This article aims to shed light on the financial performance of Vystar Corporation during this period and the potential factors contributing to these disappointing results.
A Dismal Second Quarter
Vystar Corporation's financial performance for the second quarter of 2023 was disastrous. Revenue plunged by an alarming 98.87% to a mere $0.04 million compared to $0.41 million in the same period in the previous year. This sharp decline can be attributed to the company's struggle to maintain demand for its products. Vystar Corporation also experienced a significant increase in shortfall per share, rising from $0.00 to $-0.04.

Non Invasive Monitoring Systems Inc

Non Invasive Monitoring Systems Inc Surprises Investors with Significant Fiscal Improvement, Despite Operating Loss

Investors Analyze Non Invasive Monitoring Systems Inc's Earnings and Future Performance
Experts in the Medical Equipment and Supplies industry are closely examining the fourth quarter earnings report of Non Invasive Monitoring Systems Inc (NIMU). The company reported an operating loss of $-0.033 million for the period between May and July 2023. Notably, the company has not cited any revenue for the same reporting period.
Comparatively, the operating loss for the fourth quarter of 2022 stood at $-0.035 million, serving as a crucial indicator for the overall performance of the company. As NIMU and other ascending corporations in the industry aim to develop their business strategies, the need for cost-effectiveness becomes increasingly important to progress to the next stage.

Henry Schein Inc

Despite Increased Demand, Henry Schein Inc Faces Declining Profitability in Recent Fiscal Period



Henry Schein Inc, a healthcare distributor, recently reported its financial results for the time-frame ending September 30, 2023. Despite witnessing an increase in revenue by 3.097% to $3.16 billion on a year-over-year basis, the company experienced a decline in profitability, with earnings per share (EPS) dropping by -3.67% to $1.05. This decline raises concerns about the company's performance and future prospects. We will analyze the financial data in detail to provide a comprehensive bearish outlook for Henry Schein Inc.
Revenue Growth vs. Declining Profitability:
While the company saw a modest increase in revenue from $3.07 billion to $3.16 billion compared to the previous year, profitability witnessed a significant downturn. This decline is evident through a drop in EPS from $1.09 in the corresponding period in 2022 to $1.05 in the recent financial time-frame.

Nocturne Acquisition Corporation

MBTCUs Scores Big in Third Quarter of 2023, Replicating Last Year's Success



Nocturne Acquisition Corporation, a reputable player in the financial industry, recently announced its earnings for the third quarter of 2023. While the results indicate increased deficits per share compared to the previous year, it is important to consider the broader context and acknowledge positive shifts that may impact future financial performance. This article will explore the implications of these results and shed light on the potential for a bullish outlook for Nocturne Acquisition Corporation.
Increased Deficits Per Share:
The most notable aspect of the Q3 2023 earnings report is the increase in deficits per share. Nocturne Acquisition Corporation experienced a deficit per share of $-0.11, as opposed to $-0.03 from the preceding year. This indicates a decline in profitability on a per-share basis. Additionally, the deficit grew from $-0.02 per share in the preceding reporting season. These numbers suggest that Nocturne Acquisition Corporation faced challenges during this period.

Becton Dickinson And Company

Medical Equipment and Supplies Company Witnesses Alarming Plunge in Earnings per Share Amidst Recent Fiscal Period

Becton Dickinson And Company, a medical equipment and supplies company, recently released its financial results for the fourth quarter of 2023. The company reported an income per share of $0.37 and revenue of $4.88 billion during this period. While the revenue increased by 20.459% compared to the fourth quarter of 2022, the company's income per share declined from $0.92 to $0.37. This indicates that although Becton Dickinson And Company saw significant revenue growth, their profitability decreased.
However, when compared to other companies in the Medical Equipment and Supplies sector, Becton Dickinson And Company had a much higher top-line improvement during the fourth quarter of 2023. On average, companies in this sector reported a top-line improvement of 4.80% in comparison to the same period in 2022. In contrast, Becton Dickinson And Company experienced a revenue surge of 20.459%. This suggests that the company outperformed its industry peers in terms of revenue growth.






 

Ra Medical Systems Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com